Media Room Archive

Edwards, Colo. - Can Do MS announced the 2011 dates of its CAN DO Program. The program will be held May 18 – 21 and Oct. 26 - 29 at the Lodge at Vail in Vail, Colo. 

Imagine a program dedicated exclusively to helping you live your best life with MS. A personal and powerful MS program that addresses your unique physical, emotional, social, intellectual and spiritual needs and provides you with the knowledge, skills, support and confidence to transform challenges into possibilities. Our world-renowned four-day CAN DO Program offers the industry’s most comprehensive view of multiple sclerosis, taking you on a profound exploration of your unique condition and empowering you with a whole person, whole health and whole community approach to living fully with MS.

Edwards, Colo. – Can Do Multiple Sclerosis’s free one-day JUMPSTART program, held March 19, 2011 at the Oxford Convention Center, is an educational and interactive program where people with MS and support partners learn the knowledge, skills and tools to adopt healthy lifestyle behaviors and actively co-manage their MS. This JUMPSTART Program, held in collaboration with the National MS Society, provides presentations, workshops and interactive sessions so participants can see themselves beyond the challenges of their MS.

Edwards, Colo. – An exhilarating documentary about an elite group of skiers who scale the world’s highest mountain, and challenge its most dangerous slopes, Skiing Everest will screen in a limited theatrical benefit event -January 27, 2011. 

News from the National Multiple Sclerosis Society

Exciting progress was made in 2010 in virtually every field of MS research. Progress toward finding new therapies for MS is highlighted by the availability of the first disease-modifying therapy for MS taken orally. Progress was also made toward finding ways to restore function and improving quality of life and specific MS symptoms through exercise, meditation, rehabilitation and medications, including the first therapy specifically approved to treat a symptom of MS (Ampyra). And our understanding of factors that influence whether a person develops MS deepened this year, bringing us closer to finding ways to prevent the disease.

Edwards, Colo. - Can Do Multiple Sclerosis launched a new offering called Ask The Can Do Team that allows CAN DO Program participants (people with MS and support partners) to connect with Can Do MS's interdisciplinary team of MS professionals and gain additional knowledge and skills to actively co-manage their MS and live their best lives.

Edwards, Colo. - Increase the value of your donation when you support Can Do MS on Colorado Gives Day, December 8, 2010. On this special day, Colorado is coming together to raise one million dollars in one day for nonprofits like ours.

Chicago (PRWEB)
DIME introduces MS Patient Resources, an application for the iPhone and iPod Touch, enabling clinicians to bring credible, patient-focused information to the point-of-care in the office or clinic, where they treat and counsel patients with multiple sclerosis. MS Patient Resources provides dynamic, on-demand information, ranging from scientific research and diagnostic pathways to patient-support resources.

Edwards, Colo. - Can Do MS is chosen to be one of hundreds of Colorado nonprofits that will participate in Colorado Gives Day Dec. 8, 2010. Colorado Gives Day is an initiative to increase philanthropy in Colorado through online giving, presented by Community First Foundation and FirstBank.

News from the Consortium of Multiple Sclerosis Centers

Parsippany, NJ - Neurology Reviews,^® a leading clinical news magazine for the neurology community, recently launched an interactive, multimedia microsite-Multiple Sclerosis Comprehensive Care-on the Neurology Reviews website at www.ms.neurologyreviews.com. This dedicated online resource for multiple sclerosis (MS) professionals will focus on the comprehensive approach to MS care. The microsite is sponsored by Novartis Pharmaceuticals Corporation.

News from the National Multiple Sclerosis Society

October 29, 2010 - The first drug specifically developed to treat uncontrollable laughing or crying, also called pseudobulbar affect, or PBA, has been approved by the U.S. Food and Drug Administration. Nuedexta™ (dextromethorphan hydrobromide and quinidine sulfate, formerly called AVP-923, Avanir Pharmaceuticals) is an oral therapy shown in clinical trials to significantly reduce episodes in people with MS, ALS and other disorders.

Oct. 12, 2010 - Edwards, Colo. - As part of Can Do MS's promise to honor our courageous founder's legacy and can do spirit, Can Do MS has established the Jimmie Heuga Can Do Spirit Fund used to provide people with financial assistance to attend our lifestyle empowerment programs.

GOTHENBURG, Sweden – October 15, 2010 – Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and Biogen Idec (NASDAQ: BIIB) today announced 24-week results1 from a phase II study of ocrelizumab in patients with relapsing-remitting multiple sclerosis (RRMS), the most common form2 of the disease. Ocrelizumab demonstrated a significant reduction in disease activity as measured by brain lesions and relapse rate. Patients with RRMS suffer from relapses and disabling symptoms caused by nerve damage which can significantly affect their quality of life.

East Hanover, NJ, October 7 2010 – Novartis Pharmaceuticals Corporation (http://www.us.novartis.com) today
announced the availability of patient support programs for Gilenya™ (fingolimod) 0.5 mg daily, a first-line oral treatment for relapsing forms of multiple sclerosis. Gilenya was approved by the US Food and Drug Administration (FDA) on September 21, 2010.

News from National MS Society

Congress has heard your requests and the House of Representatives passed H.R. 1362, the National Neurological Diseases Surveillance System Act. Due to your countless e-mails, phone calls, and discussions, the House of Representatives passed H.R. 1362 late last night and this bill is one significant step closer to becoming law. For the past two years, we have been working hard along with our partners in the Parkinson’s community to make this a reality.

Edwards, Colo. Sept. 22, 2010 - The Jimmie Heuga Center Endowment has contracted Mike Marolt and Montezuma Basin Productions to create a documentary film on the life of Jimmie Heuga.

A novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay
disability progression

East Hanover, NJ, September 22, 2010 – Today Novartis (http://www.novartis.com) 
announced that the US Food and Drug Administration (FDA) approved the oral multiple sclerosis (MS) treatment
Gilenya™ (fingolimod) 0.5 mg daily, a first-line treatment for relapsing forms of multiple
sclerosis – the most common forms of the disease.

Rockland, Mass and New York – Sept. 1, 2010–   EMD Serono, Inc. and Pfizer Inc
announced today that MS LifeLines, an educational and support service which includes a call
center, has achieved a milestone in servicing one million in-bound calls since its inception in
2002. MS LifeLines (http://www.mslifelines.com/pages/home?ssov=b47c269f-1c66-40f6-ab63-d326e600d8cb) sponsored by EMD Serono, Inc. an affiliate of Merck KGaA, Darmstadt, Germany, and Pfizer Inc. The service is available to the multiple sclerosis (MS) community, including people living with MS, their families and care partners.

Wine Tasting, Live music, Silent Auction & Raffle to benefit Can Do MS

Squaw Valley, Calif. • August 23, 2010 – The 22^nd Annual Alpen Wine Festival (http://www.mscando.org/calendar-of-upcoming-events/22nd-annual-alpen-wine-festival/) will be held Sunday, Sept. 5 2010 from 2 to 5 p.m. at the Village at Squaw Valley (http://www.squaw.com) to benefit Can Do Multiple Sclerosis, a national nonprofit organization and innovative provider of lifestyle empowerment programs for people with MS and their support partners. The $40 donation to Can Do MS includes a commemorative crystal wine glass, tastings from more than 40 vineyards, live music and a silent auction.

Edwards, Colo. • July 29, 2010 – Can Do Multiple Sclerosis’s free one-day JUMPSTART Program (http://www.mscando.org/multiple-sclerosis-programs/jumpstart/), held Aug. 7, 2010 at The Hotel Roanoke & Conference Center, is an educational and interactive program where people with MS and support partners learn the knowledge, skills and tools to adopt healthy lifestyle behaviors and actively co-manage their MS. This JUMPSTART Program, held in collaboration with the National MS Society, provides presentations, workshops and interactive sessions so participants can see themselves beyond the challenges of their MS. 

Edwards, Colo. • June 10, 2010 – The Can Do Multiple Sclerosis Jimmie Heuga Memorial Golf Tournament, presented by US Bank, was a huge success and raised funds for people with multiple sclerosis (MS) and their support partners. 
Tournament proceeds will fund Can Do MS’s lifestyle empowerment programs that help people with MS and their support partners nationwide transform challenges into possibilities. Can Do MS’s nationally-renowned programs include the five-day CAN DO®, two-day CAN DO 2® and one-day JUMPSTART®.  The next CAN DO Program will be held in Vail, CO at The Lodge at Vail, October 6-10, 2010.

Edwards, Colo. • April 27, 2010 – Can Do Multiple Sclerosis, formerly The Heuga Center for Multiple Sclerosis, has earned its third consecutive four-star rating, the highest rating possible, for its ability to efficiently manage and grow its finances from nonprofit evaluator Charity Navigator.  Can Do MS is in the top 13 percent of the more than 5,000 nonprofits evaluated by Charity Navigator.

MS Organizations Work Together to Improve Lives of People Living With Multiple Sclerosis

DENVER • March 26, 2010 - Can Do Multiple Sclerosis and the National Multiple Sclerosis Society announce a collaborative partnership to align resources and more effectively improve the quality of life of people living with MS and their support partners. The goal of the partnership is to go beyond traditional health and wellness programs and enable people living with MS to live their best lives.

AMPYRA Now Available by Prescription in the United States and Puerto Rico

AMPYRA Patient Support Services Available to Assist Healthcare Professionals and People with MS

HAWTHORNE, N.Y., Mar 01, 2010 (BUSINESS WIRE) -- Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that AMPYRA(TM) (dalfampridine) Extended Release Tablets, 10 mg is now available by prescription in the United States and Puerto Rico. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is indicated for use in all types of MS, and can be used either alone or with existing therapies, including disease-modifying agents.

• US Food and Drug Administration grants priority review status after accepting US regulatory submission for 0.5 mg once-daily Gilenia (fingolimod)
 
• US and European Union regulatory submissions completed in December 2009 for Gilenia include more than 4,000 patient years of clinical trial data

Basel, February 19, 2010 – Gilenia®* (FTY720, fingolimod) has been granted priority review status by the US Food and Drug Administration (FDA), which accepted the regulatory submission made in December 2009 for this medicine. Once-daily Gilenia  (0.5 mg) has the potential to become the first approved oral therapy for the treatment of multiple sclerosis (MS).

Roush Fenway Racing to Honor Can Do Multiple Sclerosis Founder and Olympic Medalist Jimmie Heuga

Daytona Beach, Fla. (Feb. 13, 2010) – Roush Fenway’s race cars will each carry a special decal honoring the life and cause of Olympic medalist skier and multiple sclerosis (MS) advocate, Jimmie Heuga, in this Sunday’s Daytona 500 race at Daytona International Speedway. Heuga passed away Monday at the age of 66 in Colorado; 46 years to the day that he won his bronze medal in the 1964 Winter Olympics.

Acorda Therapeutics Announces FDA Approval of AMPYRA™ (dalfampridine) to Improve Walking in People with Multiple Sclerosis – Demonstrated by Increases in Walking Speed

·  First and Only FDA-Approved Therapy Addressing Walking Impairment

·  AMPYRA Previously Referred to as Fampridine-SR

·  AMPYRA Expected to be Available by Prescription in March 2010

HAWTHORNE, N.Y., January 22, 2010 – Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has received marketing approval from the U.S. Food and Drug Administration (FDA) for AMPYRA™ (dalfampridine), an oral treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA demonstrated efficacy in people with all four major types of MS (relapsing remitting, secondary progressive, progressive relapsing and primary progressive). AMPYRA can be used alone or with existing MS therapies, including immunomodulator drugs.

Edwards, Colo. • Nov. 2, 2009 – Can Do Multiple Sclerosis is the new name of the nation’s leading provider of lifestyle empowerment programs for people with multiple sclerosis (MS) and their support partners, announced Kim Sharkey, CEO, Can Do MS.

The Heuga Center for Multiple Sclerosis names Dusty Boot owner John Shipp Board of Directors President

Edwards, Colo. • September 2, 2009 – The Heuga Center for Multiple Sclerosis announced John Shipp, owner of Dusty Boot Steakhouse & Saloon in Beaver Creek and Eagle, as the board of directors president. Shipp joined The Heuga Center’s board of directors in 2006 after being involved as a volunteer and fundraiser.

US FDA approves Extavia® – the first in a new portfolio of planned MS therapies from Novartis to help patients with this devastating disease

• Extavia is branded version of interferon beta-1b, a standard-of-care for multiple sclerosis in the US for more than 16 years1

• MS affects around 400,000 people in US2 – one of the most common neurological disorders in young adults3

• FDA approval marks important step forward for Novartis, laying foundation for innovative approach to treatment of MS

East Hanover, NJ, August 17, 2009 – The US Food and Drug Administration (FDA) has approved Extavia® (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients manage this devastating disease.

The Heuga Center for Multiple Sclerosis' board and staff are excited to be engaged in a comprehensive branding process and renewed broad-scale marketing effort. As part of this new branding effort, we made the strategic decision to transition to a name that best reflects our identity and value. Our identity and value builds on Jimmie Heuga's vision and positive can do core philosophy that inspires people to act on the belief that they are more than their MS.

Edwards, Colo. • August 12, 2009 – The Heuga Center for Multiple Sclerosis is proud to announce that it has received a $10,000 Quality of Life grant from the Christopher & Dana Reeve Foundation.  The award was one of 86 grants totaling almost $500,000 awarded by the Reeve Foundation to nonprofit organizations nationwide that help people living with paralysis and their families become more integrated members of society.  Since inception of the program in 1999, nearly 1,600 grants have been awarded, totaling almost $13 million.

Becomes first campaign fundraising and public education director

Edwards, Colo. • March 13, 2009 – Jimmie Heuga, founder of The Heuga Center for Multiple Sclerosis (MS), has been appointed the first campaign fundraising and public education director for the Jimmie Heuga Center Endowment, the Endowment Board announced. In this outreach role, Jimmie will raise awareness and solicit contributions to support The Heuga Center for Multiple Sclerosis’s health and wellness programs and services now and in perpetuity.

Edwards, Colo. • February 20, 2009 –The Heuga Center for Multiple Sclerosis’ Board of Directors appointed Kim Sharkey, previously Interim Chief Executive Officer and Chief Operating Officer, to Chief Executive Officer (CEO). The Heuga Center’s nominating committee, in conjunction with Colorado-based JVA Consulting, conducted a thorough assessment of needs and capabilities to ensure the organization continues to lead the way with nationally-renowned health and wellness programs for people and families living with multiple sclerosis (MS).

February 11, 2009 – The Heuga Center for Multiple Sclerosis earned four stars, the highest rating possible, for the second consecutive year from nonprofit evaluator Charity Navigator this month for its ability to efficiently manage and grow its finances. The Heuga Center is in the top 18 percent of the 5,000 nonprofits evaluated by Charity Navigator.

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced the submission of a New Drug Application to the U.S. Food and Drug Administration (FDA) on January 30, 2009 for Fampridine-SR, a novel therapy being developed to improve walking ability in people with multiple sclerosis (MS). The Company expects that the NDA filing, if accepted, will be subject to standard review, which would provide a target for the FDA to complete its review within ten months from receipt of the submission.

This information is provided for research purposes only and does not constitute an endorsement by The Heuga Center. The brands listed are registered trademarks of their respective owners.

Do you want a treatment that is effective, easy to take and minimizes side effects? So do we. Join us in researching laquinimod, an investigational oral drug for MS.

Olympic Valley, CA. (August 1, 2008) – Ever had a Midlife Crisis in a glass? Or sipped from a Twisted River?  These are just two of the more than 40 Northern California wineries that will be present at the 20th Annual Alpen Wine Festival hosted by The Village at Squaw Valley USA and Uncorked Wine Bar on Sunday, August 31st 2008.  Former Olympic ski racer Jimmie Heuga will join wine aficionados at the event, which will help raise money for The Heuga Center for Multiple Sclerosis.

Edwards, Colo. • June 24, 2008 – Today the World Sports Humanitarian Hall of Fame (www.SportsHumanitarian.com) inducts former Olympic skier and Colorado resident Jimmie Heuga at the Hall’s annual ceremony in Boise. Heuga is honored as founder of The Heuga Center for Multiple Sclerosis, a nonprofit organization that provides innovative health and wellness programs to improve the quality of life for people with multiple sclerosis (MS).

Edwards, Colo. • June 13, 2008 –  The 15th Annual Heuga Center Golf Tournament, presented by Slifer Smith & Frampton Real Estate, raised funds for people and families living with multiple sclerosis (MS) June 9, 2008 at the Cordillera Mountain Course.  Proceeds will fund The Heuga Center for Multiple Sclerosis’ health and wellness programs that empower people and families living with MS to transform and improve their quality of life.  The Heuga Center’s nationally-renowned programs are five-day CAN DO two-day CAN DO 2 and one-day JUMPSTART.  The Center’s CAN DO program is in Vail, Colo., November 5-9 at The Lodge at Vail. 

Edwards, Colo. • June 1, 2008 – Colorado Footwear will hold The 3rd Annual Stepping Up for MS – The Shoe Sale with Soul at the International Bridge in Vail Village on June 21, 2008.  One hundred percent of the proceeds benefit the Edwards-based Heuga Center for Multiple Sclerosis (MS).  The sale will feature shoes marked 50 – 70 percent off the retail price. 

Report of a CMSC Consensus Conference
November 28–29, 2007

Brian Hutchinson, PT, MSCS; Susan J. Forwell, PhD, (OT)C, FCAOT; Susan Bennett, PT, EdD, NCS, MSCS; Theodore Brown, MD, MPH; Herb Karpatkin, PT, MSCS; Deborah Miller, PhD, LISW

Edwards, Colo. • Nov. 27, 2007 – The Heuga Center for Multiple Sclerosis earned four stars, the highest rating possible, from nonprofit evaluator Charity Navigator this month for its ability to efficiently manage and grow its finances.  Charity Navigator is the nation’s largest and most-utilized, independent evaluator of nonprofit organizations. 

Edwards, Colo. • September 17, 2007 – Kickapoo Tavern in Keystone, Colo. will donate 50 percent of their sales from Sept. 26 - 30, 2007 to The Heuga Center for Multiple Sclerosis (MS) during its Dine Out for MS fundraising event.  To participate in Dine Out for MS and help people and families living with MS, families and friends can eat lunch or dinner from 12 p.m. to 9 p.m. at Kickapoo Tavern any days from Sept. 26 - 30.

Edwards, Colo. • July 26, 2007 – The Heuga Center for Multiple Sclerosis will honor the Multiple Sclerosis (MS) Coalition at The Heuga Center’s 22nd Annual Autumn Benefit October 23, 2007 at the St. Regis Hotel in New York City.  The MS Coalition is an affiliation of independent MS organizations dedicated to the enhancement of the quality of life for those affected by MS.

Rockland, Mass. • July 2, 2007 – EMD Serono, Inc. today announced the launch of a new program, MS LifeLines® Access Made Simple, which provides simplified and affordable access to therapy for people with relapsing forms of multiple sclerosis (MS) who have either been newly prescribed Rebif (interferon beta-1a) by their physician or who have restarted Rebif therapy after having discontinued for more than 90 days.  This program is only available to patients in the U.S.

Edwards, Colo. • May 25, 2007 – The 14th Annual Heuga Center Golf Tournament, presented by Slifer Smith & Frampton Real Estate, is June 3-4, 2007 at Cordillera in Edwards, Colo.  The tournament’s proceeds fund The Heuga Center for Multiple Sclerosis’ nationally-renowned comprehensive programs that empower people and families living with multiple sclerosis (MS) to transform and improve their quality of life.

Beaver Creek Restaurant to Donate Sales Proceeds to The Heuga Center for Multiple Sclerosis

Edwards, Colo. • May 1, 2007 – Swing into The Dusty Boot Steakhouse & Saloon from May 17 to 23 and help improve the lives of people affected by multiple sclerosis (MS).  Restaurant owner John Shipp will donate 50% of sales proceeds from the weeklong event to The Heuga Center for MS.

SUMMIT COUNTY DINE OUT FOR MS AT KICKAPOO TAVERN, WOLF ROCK BREWERY, TADDEO’S AND QUANDARY GRILLE APRIL 16-22 

Restaurants to Donate Sales Proceeds to The Heuga Center for Multiple Sclerosis 

Edwards, Colo. • April 5, 2007 – From April 16 to 22, join Kickapoo Tavern, Wolf Rock Brewery, Taddeos and Quandary Grille in improving the lives of people affected by multiple sclerosis (MS).  Restaurant owner John Shipp, in collaboration with The Heuga Center for Multiple Sclerosis, will donate 50% of sales proceeds from the weeklong event.  

Colorado Footwear presents:
The 2nd Annual Stepping Up for MS—A Shoe Sale with Soul

Benefiting The Heuga Center for Multiple Sclerosis

Edwards, Colo. • March 20, 2007 - Colorado Footwear will hold The 2nd Annual Stepping Up for MS – A Shoe Sale with Soul at the International Bridge in Vail Village on April 7, 2007.  100% of the proceeds benefit the Edwards-based Heuga Center for Multiple Sclerosis (MS), a leading international non-profit organization helping people and families living with MS through innovative programs and services.

Grant to have direct impact on people living with paralysis in Colorado

Edwards, Colo. - March 5, 2007 - The Christopher Reeve Foundation (CRF) announced today that THE HEUGA CENTER FOR MULTIPLE SCLEROSIS has been awarded a $10,000 Quality of Life grant.  The CRF awarded a total of $717,404 in Quality of Life grants to 90 nonprofit organizations around the world.  Since 1999, when the Quality of Life program was conceived by the late Dana Reeve as a way for the CRF to help improve the day-to-day health and well-being of those living with paralysis, 1,163 grants totaling $9,220,980 have been awarded.

Challenge the Mountain. Challenge Yourself. Change Lives!

Edwards, Colo. • Dec. 2006 – The 2007 Vertical Express for Multiple Sclerosis (MS), presented by Fred Alger Management and Rolex Watch USA, hits the snowy slopes of eleven resorts across the U.S. and Canada. Skiers and riders of all ages and abilities will challenge the mountain, challenge themselves, and change lives. Proceeds benefit The Heuga Center for Multiple Sclerosis, a leading international non-profit organization helping people and families living with MS through innovative programs and services.

Edwards, Colo. • Dec. 4, 2006 – Artists face every kind of challenge getting their work recognized but for a group of talented artists who have multiple sclerosis, having their work seen will no longer be one of those challenges. The Heuga Center for Multiple Sclerosis (MS) has chosen the photography, paintings and pottery of four artists with MS and will feature this artwork on elegant 5 X 7 greeting cards.

Edwards, Colo. • Oct. 27, 2006 – Actress Teri Garr was honored this week in New York City by The Heuga Center for Multiple Sclerosis for her spirit and work advancing awareness about multiple sclerosis (MS) and how to live a positive life with this incurable disease. Garr received the Can Do Award during the 21st Annual Heuga Center Autumn Benefit presented by Rolex Watch USA and Serono, Inc./Pfizer. The black tie gala took place October 24 at the St. Regis Hotel in New York and was attended by 180 guests from across the country. The event raised important funds to support The Heuga Center’s programs for people with MS.